LONDON (dpa-AFX) – AstraZeneca (AZN, AZN.L, ZEG.DE, AZN.ST) said the FDA has informed that it will extend the PDUFA date to review additional data requested to support the New Drug Application for…
AstraZeneca: FDA Extends PDUFA Date Related To NDA For Camizestrant
Source: Finanznachrichten.de
Read Full Story →
